Brief: Reneo Pharmaceuticals Q1 Loss Per Share $3.48
May 20 (Reuters) - Reneo Pharmaceuticals Inc RPHM.O :
* RENEO PHARMACEUTICALS REPORTS FIRST QUARTER 2021 FINANCIAL
RESULTS
* Q1 LOSS PER SHARE $3.48
* QTRLY LOSS $3.48 PER SHARE
Source text for Eikon: ID:nGNX6hT2rp
Further company coverage: RPHM.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Onkure Therapeutics
See all newsBrief: Onkure Therapeutics Inc Files For Mixed Shelf Of Up To $200 Million - SEC Filing
Onkure Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Onkure Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary
Onkure Therapeutics Inc expected to post a loss of $1.46 a share - Earnings Preview
U.S. RESEARCH ROUNDUP-F5, Nextracker, Stryker